Fenwal Inc.

Experts to Re-examine Guidance for Platelet Testing

William Cork Joins Fenwal as Chief Technology Officer

Improving Transfusion Safety: Fenwal, Verax Biomedical Sign Agreement for Rapid, Point-of-Care Bacteria Test

LAKE ZURICH, Illinois, November 17 - Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that the U.S.

MORE..

LAKE ZURICH, Illinois, November 10 - Fenwal Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today William H.

MORE..

Older News

LAKE ZURICH, Illinois - Fenwal Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today it has signed a five-year exclusive worldwide agreement with Verax Biomedical Incorporated to market, sell and distribute Verax's unique PanGenera(R) Detection (PGD) technology, a rapid diagnostic test used to detect bacterial contaminants in donated blood platelets.

MORE..